A-TECH 1300, PART A

APPLIED TECHNOLOGIES

Revision date : 2013-08-23

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 1
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

101-68-8

Name of the chemical

4,4’-Methylenediphenyl diisocyanate

Concentration

55-60

EC/CAS

9016-87-9

Name of the chemical

4,4'-Methylendiphenyldiisocyanat tech. (Polymeres) MDI, pMDI (in Form atembarer Aerosole, A-Fraktion)

Concentration

25-30

EC/CAS

91-20-3

Name of the chemical

Naphthalene,3

Concentration

10 ppm

General Information

Revision date

2013-08-23

Product name

A-TECH 1300, PART A

Manufacturer Name

APPLIED TECHNOLOGIES

Emergency telephone

1-800-424-9300

Icons in SDS

Company Information

company name

APPLIED TECHNOLOGIES

GHS Information

Signal word

WARNING!

Section 2

SECTION 2: Hazards identification

WARNING! Color: Colorless to Pale yellow to Dark Brown. Form: liquid Odor: Slight, Musty. Toxic gases/fumes may be given off during burning or thermal decomposition. Closed container may forcibly rupture under extreme heat or when contents have been contaminated with water. Use cold water spray to cool fire-exposed containers to minimize the risk of rupture. Causes respiratory tract irritation. May cause allergic respiratory reaction. Harmful if inhaled. Respiratory sensitizer. Lung damage and respiratory sensitization may be permanent. Causes skin irritation. May cause allergic skin reaction. Skin sensitizer. Animal tests and other research indicate that skin contact with this product can play a role in causing isocyanate sensitization and respiratory reaction. Causes eye irritation. May cause lung damage. WARNING! FLAMMABLE OR COMBUSTIBLE LIQUID AND VAPOR. MAY AFFECT THE CENTRAL NERVOUS SYSTEM CAUSING DIZZINESS, HEADACHE OR NAUSEA. MAY CAUSE RESPIRATORY TRACT IRRITATION. MAY BE HARMFUL IF INHALED OR SWALLOWED. PROLONGED OR REPEATED CONTACT MAY DRY THE SKIN AND CAUSE IRRITATION AND BURNS.

Potential health effects

EYE Acute Eye Causes irritation with symptoms of reddening, tearing, stinging and swelling. May cause temporary corneal injury. Chronic Eye Prolonged vapor contact may cause conjunctivitis. SKIN Acute Skin Causes irritation with symptoms of reddening, itching, and swelling. Chronic Skin Prolonged contact can cause reddening, swelling, rash, and in some cases, skin sensitization and even respiratory reaction. Passage of this material into the body through the skin is possible. INGESTION: May cause irritation; symptoms may include abdominal pain, nausea, vomiting, and diarrhea. Signs and symptoms of exposure to this material through breathing, swallowing, and/or passage of the material through the skin may include:, sweating, fever, stomach or intestinal upset (nausea, vomiting, diarrhea), irritation (nose, throat, airways), lung irritation, central nervous system depression (dizziness, drowsiness, weakness, fatigue, nausea, headache, unconsciousness), pain in the abdomen, frequent or painful urination, confusion, blood abnormalities (breakage of red blood cells), kidney damage, lung damage, respiratory failure. Damage to lungs may result if solvents are ingested then vomited. INHALATION: Inhalation at levels above the occupational exposure limit could cause respiratory sensitization and risk of serious damage to the respiratory system. The onset of respiratory symptoms my be delayed for several hours after exposure. A hypersensitive response to even minimal concentrations of diisocyanates may develop in sensitized persons. Inhalation symptoms: Diisocyante vapors or mist at concentrations above the TLV or PEL can irritate (burning sensation) the mucus membranes in the respiratory tract (nose, throat, lungs) causing runny nose, sore throat, coughing, chest discomfort, shortness of breath and reduced lung functions (breathing obsruction). Persons with a preexisting, nonspecific bronchial hypersensitivity can respond to concentrations below the TLV or PEL with similar symptoms as well as asthma attack or asthma-like symptoms. Exposure above the TLV or PEL may lead to bronchitis, bronchial spasm and pulmonary edema (fluid in the lungs), chemical or hypersensitivity pneumonia, with flu-like symptoms (e.g., fever, chills) has also been reported. These symptoms can be delayed up to several hours after exposure. These effects are usually reversible. Chronic inhalation: As a result of previous repeated overexposure or a single large dose, certain individuals may develop sensitization to diisocyanates (asthma or asthma-like symptoms) that may cause them to react to a later exposure to diisocyanates at levels well below the TLV or PEL. These symptoms, which can include chest tightness, wheezing, cough, shortness of breath and asthma attack, could be immediate or displayed up to several hours after exposure, Extreme asthmatic reactions can be life threatening. Similar to many nonspecific asthmatic responses, there are reports that once sensitized an individual can experience these symptoms upon exposure to dust, cold air or other irritants. This increased lung sensitivity can persist for weeks and in severe cases for several years. Sensitization can be permanent. Chronic overexposure to diisocyanates has also been reported to cause lung damage (including fibrosis, decrease in lung function) that may be permanent.

Medical Conditions Generally Aggravated by Exposure

Skin Allergies, Eczema, Asthma, Respiratory disorders. All applicants who are assigned to an isocyanate work area should undergo a pre-placement medical evaluation. A history of eczema or respiratory allergies such as hay fever, are possible reasons for medical exclusion from isocyanate areas. Applicants who have a history of adult asthma should be restricted from work with isocyanates. Applicants with a history of prior isocyanate sensitization should be excluded from further work with isocyanates. A comprehensive annual medical surveillance program should be instituted for all employees who are potentially exposed to diisocyanates. Once a worker has been diagnosed as sensitized to any isocyanate, no further exposure can be permitted. CHRONIC INFORMATION: . Respiratory sensitizer. CARCINOGENICITY: NTP CARCINOGEN-Yes IARC MONOGRAPHS-Yes OSHA CARCINOGEN-No TERATOLOGY (BIRTH DEFECT) INFORMATION: Information not found REPRODUCTION INFORMATION: Information not found. EINECS EUROPEAN SAFETY AND

Hazard statements

S7/8, R42/43, R48/23/24 S20/21 When using do not eat, drink or smoke. R7 May cause fire

HMIS CODES

H F R P =2*21Hopsu

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.